TipRanks on MSN

GenFleet Therapeutics launches pioneering Phase III study for pancreatic cancer treatment

Genfleet Therapeutics (Shanghai), Inc. Class H ( ($HK:2595) ) just unveiled an announcement. GenFleet Therapeutics has initiated the first ...

Novo Nordisk still sees potential for GLP-1 drugs for Alzheimer’s, despite trial setback

Novo Nordisk says it still thinks GLP-1 drugs could be a promising treatment for Alzheimer’s, despite two disappointing ...

Receptor with 'rubber band' paves way for new pain and cancer drugs

The human P2X4 receptor plays an important role in chronic pain, inflammation and some types of cancer. Researchers at the ...
The American Journal of Managed Care

The Expanding Role of Biologics in Treatment for Metabolic Syndrome

A review article discussed the expanding role of biologics in treating components of metabolic syndrome, including glucagon-like peptide 1 (GLP-1) analogs for type 2 diabetes and obesity and ...